Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.
Iron deposition in the precentral grey matter in patients with multiple sclerosis: A quantitative study using susceptibility-weighted imaging.
Induction of cognitive fatigue in MS patients through cognitive and physical load.
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
The fumaric acid ester BG-12: a new option in MS therapy.
Bilateral Optic Neuritis-The Only Ocular Finding in a Case of Subacute Sclerosing Panencephalitis.
Comparison of the Effect of 8 weeks Aerobic and Yoga Training on Ambulatory Function, Fatigue and Mood Status in MS Patients.
Cognitive evaluation by tasks in a virtual reality environment in multiple sclerosis.
Diffusion Tensor Analysis of Pediatric Multiple Sclerosis and Clinically Isolated Syndromes.
Microcystic macular oedema confirmed, but not specific for multiple sclerosis.
Diffusion tensor imaging in pediatric transverse myelitis: A case study.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Targeting cells in motion: migrating toward improved therapies.
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
A Friend in Need may not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients.
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
Pages
« first
‹ previous
…
373
374
375
376
377
378
379
380
381
…
next ›
last »